SLC39A8 and prostate carcinoma: In vitro studies using the prostate cancer cell line PC3 (versus control) have also shown the downregulation of ZIP5, ZIP7, ZIP8, ZIP11, ZIP12, and ZIP13 [70], which needs to be confirmed by other studies.